On-Target Rate Quotes & Company in Brazil

Understanding On-Target Rate: The Key to Cost-Effective Genomics

In the realm of Next-Generation Sequencing (NGS) and targeted enrichment, the on-target rate is a vital performance metric. It defines the percentage of sequenced reads that align successfully to the target regions of interest (such as exons in whole-exome sequencing or specific loci in custom gene panels) relative to the total reads generated. A high on-target rate indicates that the sequencing run was highly specific, yielding maximum data for the targeted regions while minimizing wasted reads on off-target genomic noise. For research labs and clinical institutions, optimizing this rate directly translates to lower sequencing depths required per sample, thereby significantly reducing overall operational costs.

The Genomics Industry and Market Landscape in Brazil

Brazil represents the largest biotechnology and life sciences market in Latin America. With a robust academic network including institutions like the University of São Paulo (USP), State University of Campinas (UNICAMP), and the Oswaldo Cruz Foundation (Fiocruz), the demand for genomic sequencing has grown exponentially. In recent years, Brazil’s industrial sectors—ranging from agribusiness to clinical diagnostics—have increasingly integrated genomic data into their core workflows. However, local researchers face unique challenges, such as high import taxes on reagents and long transit times for international shipments. Consequently, obtaining competitive on-target rate quotes from a reliable global partner like BMKGene is essential for local laboratories to optimize their budgets and achieve international sequencing standards.

Localized Application Scenarios for Targeted Sequencing in Brazil

Targeted sequencing applications in Brazil are highly localized to address the country's unique ecological, economic, and medical demands:

• Agricultural Breeding & Crop Protection: Crop scientists at EMBRAPA and private agricultural firms use targeted genotyping panels to screen thousands of soybean, sugarcane, and maize varieties for drought tolerance and pest resistance. Achieving a high on-target rate ensures cost-effective screening across large cohorts.
• Metagenomic Surveillance: Given Brazil's vast biodiversity, researchers utilize amplicon sequencing (16S/18S/ITS) to profile soil microbiomes in agricultural soils, optimizing bio-fertilizer applications and monitoring soil health.
• Admixed Population Genetics: The Brazilian population is highly admixed, combining European, African, and Indigenous ancestries. Targeted panels designed with high specificity help clinical geneticists identify population-specific risk variants without the prohibitive costs of whole-genome sequencing.

Biomarker Technologies (BMKGene): Corporate Overview

Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.